Drug search by name

Lenvima 4 MG Daily Dose and Hepatic impairment

Result of checking the interaction of drug Lenvima 4 MG Daily Dose and disease Hepatic impairment for safety when used together.

Check result:

Lenvima 4 MG Daily Dose <> Hepatic impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Hepatic failure, including fatal events have been reported with the use of lenvatinib. No dose adjustment is recommended in patients with mild or moderate hepatic impairment. Dose adjustment is needed in patients with severe hepatic impairment. It is recommended to monitor liver function before initiation of therapy with lenvatinib and regularly thereafter as clinically indicated. It might be necessary to temporarily withhold the use of lenvatinib and either resume at a reduced dose or discontinue treatment with lenvatinib depending on the severity and persistence of hepatic impairment. Discontinue treatment with lenvatinib for hepatic failure.

Lenvima 4 MG Daily Dose

Generic Name: lenvatinib

Brand Name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose

Synonyms: Lenvima

What is Lenvima 4 MG Daily Dose?